EUCTR2013-001967-22-GB进行中（未招募）1 期
A phase II study to investigate the protective effects of Glucagon-like Peptide-1 (GLP-1) in patients undergoing elective angioplasty and stenting. - GLP-1 loading during elective PCI (GOLD-PCI)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Undergoing elective PCI
- •Age over 18
- •Able to give informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 200
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 200
排除标准
- •Severe comorbidity (expected life expectancy < 6 months)
- •Nicorandil, sulphonylurea, DPP4 inhibitor, GLP1 receptor agonist, and insulin use
- •Women of child bearing age
- •Breastfeeding women
- •Myocardial infarction within the previous 6 weeks
- •Chronic Renal Impairment (serum creatinine > 200 µmol/l)
研究者
相似试验
招募中
2 期
Effect of tranilast on facial neuralgiaTrigeminal neuralgiaTrigeminal neuropathic painTrigeminal NeuralgiaJPRN-jRCTs061230013Ikutame Daisuke15
尚未招募
2 期
Phase II study to evaluate the preventive effect and safety of lubiprostone in opioid-induced constipatiocancer painJPRN-jRCTs051230150Kuriyama Toshiyuki37
已完成
2 期
A Phase 2 study to investigate the efficacy, safety, and tolerability of six weeks treatment with V565 in subjects with active Crohn*s disease<br>Enteritis Regionalis10017969Crohn's DiseaseNL-OMON47571VHsquared Ltd6
进行中（未招募）
1 期
A clinical study testing the efficacy and safety of V565 in patients with Crohn's DiseaseEUCTR2016-002939-15-NLVHsquared Ltd126
进行中（未招募）
1 期
A clinical study testing the efficacy and safety of V565 in patients with Crohn's DiseaseActive Crohn's DiseaseMedDRA version: 20.0 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disordersEUCTR2016-002939-15-DEVHsquared Ltd126